FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma

Schittenhelm J1 2, Ziegler L2, Sperveslage J3 4, Mittelbronn M5 6 7 8 9, Capper D10 11, Burghardt I1 12, Poso A13, Biskup S14, Skardelly M1 15, Tabatabai G1 12 16 17
  1. Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  2. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  3. Department of Pathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  4. Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.
  5. Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg.
  6. Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  7. National Center of Pathology (NCP), Laboratoire National de Santé (LNS), Dudelange, Luxembourg.
  8. Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
  9. Edinger Institute (Neurological Institute), University of Frankfurt, Frankfurt, Germany.
  10. Institute of Neuropathology, Berlin Institute of Health, Berlin, Germany.
  11. Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  12. Department of Neurology & Interdisciplinary Neurooncology, University Hospital Tübingen, Hertie-Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tuebingen, Germany.
  13. Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
  14. CeGaT GmbH and Praxis für Humangenetik Tuebingen, Tuebingen, Germany.
  15. Department of Neurosurgery, University Hospital of Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  16. Center for Personalized Medicine, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  17. German Consortium for Translational Cancer Research (DKTK), DKFZ partner site Tuebingen, Tuebingen, Germany.